The following day, we transferred the slices to the device and exposed them to CP for 24 hours (sometimes used for GBM chemotherapy alone or in combination with temozolomide), buffer (control for CP), staurosporine (STS, a non-selective protein kinase inhibitor), or DMSO (vehicle control for STS), as shown in Fig. 7a. The gene discussed is CP; the disease is glioblastoma.